Table 2. Baseline data table of train and test tets after sample balancing.
| Characteristics | Train set | Pvalue | Test set | P value | ||
|---|---|---|---|---|---|---|
| NBM (n = 12, 762) | BM (n = 2, 556) | NBM (n = 5, 477) | BM (n = 1, 089) | |||
| Sex, n (%) | 0.135 | 0.776 | ||||
| Male | 5,206 (34%) | 1,002 (6.5%) | 2,188(33.3%) | 430 (6.5%) | ||
| Femal | 7,556 (49.3%) | 1,554 (10.1%) | 3,289 (50.1%) | 659 (10%) | ||
| Grade, n (%) | <0.001 | <0.001 | ||||
| 1 | 3,172 (20.7%) | 255 (1.7%) | 1,377 (21%) | 103 (1.6%) | ||
| 2 | 5,766 (37.6%) | 1,237 (8.1%) | 2,477 (37.7%) | 536 (8.2%) | ||
| 3 | 3,747 (24.5%) | 1,058 (6.9%) | 1,592 (24.2%) | 446 (6.8%) | ||
| 4 | 77 (0.5%) | 6 (0%) | 31 (0.5%) | 4 (0.1%) | ||
| TumorSite, mean ± sd | 2.767 ± 1.3611 | 2.6099 ± 1.3242 | <0.001 | 2.7674 ± 1.3956 | 2.5849 ± 1.3041 | <0.001 |
| TStage, n (%) | <0.001 | <0.001 | ||||
| T1 | 8,740 (57.1%) | 1,294 (8.4%) | 3,736 (56.9%) | 545 (8.3%) | ||
| T2 | 2,152 (14%) | 327 (2.1%) | 955 (14.5%) | 136 (2.1%) | ||
| T3 | 1,136 (7.4%) | 497 (3.2%) | 451 (6.9%) | 229 (3.5%) | ||
| T4 | 734 (4.8%) | 438 (2.9%) | 335 (5.1%) | 179 (2.7%) | ||
| NStage, n (%) | <0.001 | <0.001 | ||||
| N0 | 9,524 (62.2%) | 696 (4.5%) | 4,163 (63.4%) | 292 (4.4%) | ||
| N1 | 1,008 (6.6%) | 315 (2.1%) | 395 (6%) | 126 (1.9%) | ||
| N2 | 1,807 (11.8%) | 1,247 (8.1%) | 722 (11%) | 552 (8.4%) | ||
| N3 | 423 (2.8%) | 298 (1.9%) | 197 (3%) | 119 (1.8%) | ||
| TumorSize, mean ± sd | 19.859 ± 6.3537 | 22.569 ± 5.854 | <0.001 | 19.625 ± 6.3399 | 22.017 ± 5.8392 | <0.001 |
| Race, n (%) | <0.001 | <0.001 | ||||
| White | 11,616 (75.8%) | 2,308 (15.1%) | 4,983 (75.9%) | 994 (15.1%) | ||
| Black | 0 (0%) | 98 (0.6%) | 0 (0%) | 33 (0.5%) | ||
| Other | 1,146 (7.5%) | 150 (1%) | 494 (7.5%) | 62 (0.9%) | ||
| Age, mean ± sd | 67.562 ± 10.143 | 66.028 ± 10.838 | <0.001 | 67.721 ± 10.165 | 66.185 ± 10.658 | <0.001 |
| Marital, n (%) | <0.001 | <0.001 | ||||
| Yes | 7,112 (46.4%) | 1,855 (12.1%) | 3,093 (47.1%) | 777 (11.8%) | ||
| No | 5,650 (36.9%) | 701 (4.6%) | 2,384 (36.3%) | 312 (4.8%) | ||
Notes.
- NMB
- no bone metastasis
- BM
- bone metastasis